Session 8: Towards patient-centered medicine

  • Experiences with shared decision-making in patients with endometriosis 
  • The quality of care delivered to patients from the patient perspective
  • A patient experience 
  • Roundtable discussion with representatives of patient associations

 Session 7:  Chronic pelvic pain at different stages of life.

  • Sexuality and pelvic pain through the life span 
  • Vestibulodynia versus vaginismus 
  • Vulvodynia in the elderly woman: Genitourinary syndrome of the menopause, and dermatological disorders. Diagnostic approach and therapeutic proposals 
  • Erectile dysfunction, orgasm and pain 
  • Pregnancy and childbirth in patients with chronic pelvic pain 

Discussion

Session 2: Endometriosis and Pain

  • Mechanisms of pain in Endometriosis 
  • Medical treatment for endometriosis pain: an update 
  • Non-pharmacological and non-surgical therapies for endometriosis pain 
  • Predictors of treatment failure in patients with endometriosis-associated chronic pelvic pain 
  • Recurrence of pain after surgery, what to do?

Discussion

Session 1: Transition from acute to chronic pain. Central sensitization.

  • Visceral chronic pain in the absence of injury: how to change paradigms 
  • When pain uncouple from harm: what do we understand for central sensitization? 
  • How can we diagnose central sensitization? 
  • When to operate and when not to operate? 
  • How how to manage a patient with central sensitisation for surgery/peri-operatively  

Discussion

Workshop 2: Multidisciplinary management, from theory to practice

Clinical cases: Management of pelvic and perineal pain.
Discussion of 3 clinical scenarios by a panel of experts, to represent a multidisciplinary team of a chronic pelvic pain clinic. (3 blinded clinical cases), emulating a clinical committee on chronic pelvic pain. 
Theory is great, but how do you do it in practice?

Workshop 1: Infiltration and nerve block techniques

  • Trans-gluteal truncal and radicular diagnostic infiltrations
  • Infiltration of local anaesthetics / botulinum toxin in the levator ani, piriformis and internal obturator muscles 
  • Blockade of the coccyx, the sacroiliac joint and the ganglion impar 

Discussion

Session 6 : Pelvic pain, chronicity and mental health

  • Anhedonia and chronic pain 
  • Trauma-informed  strategies and practices for physiotherapy: Working with complex trauma, sexual assault survivors in physiotherapy 
  • What does it mean to be anally retentive? Characteristics of anal personality and chronic pain 
  • Revelation and/or evocation of traumatic events during an interview: What to do and for what purpose? 

Discussion

Session 5: Pelvic pain in the primary care setting.

  • How to improve ambulatory management of chronic pelvic pain? 
  • What are the basics of the clinical examination and complementary tests? 
  • The role of the general practitioner and the emergency physician in dealing with chronic pelvic pain 
  • The role of the physiotherapy in initial care 

Discussion

Session 4: Coccygodynia, search for a consensus 

  • Diagnosis and pathophysiological mechanisms 
  • Association of coccydynia and pudendal neuralgia. 
  • Manual therapy for the treatment of coccygodynia 
  • Medical and surgical management of coccygodynia. 

Discussion

Session 3: Neuroscience of movement in pelvic pain

  • Biomechanics of the pelvis 
  • Therapeutic exercise in chronic pain 
  • Involvement of walking in chronic pelvic pain. Relationship between goat and chronic pelvic pain.
  • Pyramidal syndrome in chronic pelvic pain. 
  • Lumbar pathology and chronic pelvic pain 

Discussion

Abstracts

Abstract submission portal

Portal
New deadline for abstract submission: 11 September 2023

General information

  • All abstracts must be received before 11 September through the On-line Abstract Submission Platform.
  • The abstract text must be anonymous without any authors’ or institutions’ names. Do not include the name of the hospital, university or city.
  • All abstract identification details, references, affiliations will be taken separately as part of the online submission process and will be merged again with the abstract text after review.
  • Abstracts must be original and should not have been published or presented at any conferences prior to the Convergences PP Annual Meeting.
  • By submitting your abstract, you give permission to the CONVERGENCES PP to publish the abstract in the congress promotional material (brochures, CONV PP websites). In addition, if your abstract is accepted, you must be registered at the congress in order to present your paper.
  • All abstracts will be reviewed by the Scientific Program Committee of the Meeting, and reviewing results will be emailed to the author who sent the abstract by 25th September, 2023

Instructions

Please read the following instructions carefully before preparing your abstract:

  • Abstract must be submitted through the online system for abstract submission, in ENGLISH
  • Abstracts must contain no more than 300 words and must be anonymous. Authors’ names and affiliations should not be included in the text.
  • Use standard abbreviations and place a special or unusual abbreviation in parentheses after the full word appears. Write numbers as numerals rather than words.

Presentation type

  • Oral presentation
  • Poster presentation

Topics

  • CHRONIC PELVIC PAIN
  • URINARY AND ANAL DYSFUNCTION
  • NEUROPATHIC PAIN
  • MYO-FASCIAL PAIN
  • AUTONOMIC PAIN
  • UROLOGICAL PAIN
  • GENITAL PAIN AND DYSFUNCTION
  • ENDOMETRIOSIC PAIN
  • ANO-RECTAL PAIN
  • POST-DELIVERY PAIN
  • POST-OP PELVIC PAIN
  • POST-TRAUMA PAIN
  • IRRITABLE BOWEL SYNDROME
  • PELVIC VEIN CONGESTION SYNDROME
  • PELVIC PAIN AND POSTURE DYSFUNCTION
  • COCCYGODYNIA
  • PELVIC SENSITIZATION
  • BUTTOCK PAN

Important remarks

  • Authors are strongly advised to ensure the accuracy of the submitted abstracts. Any mistakes in literature or in scientific facts will be published as typed.
  • The Scientific Program Committee of the Convergences PP Annual Meeting reserves the right to accept or refuse an abstract, to designate abstracts for either oral or poster presentation and to choose a suitable session for the abstract. The authors’ preference on presentation type and subject will be taken into account.
  • Presenters of accepted abstracts must register  for the Congress.
  • Submission of the abstract implies the authors consent to publication.

Abstract notification

Notification regarding abstract acceptance/rejection will be sent to the author who has submitted the abstract by 25th September 2023.